Natera $400 million follow-on offering
The shares are listed on Nasdaq
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Alight $178 million debut secondary offering
The stock is listed on the NYSE
Kinsale Capital Group follow-on offering
The stock is listed on the NYSE
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Lucid $600 million at-the-market offering and $915 million additional investment
The common stock is listed on Nasdaq
Equinix $1.5 billion at-the-market offering
We advised the company on the SEC-registered at-the-market offering
PGE stock offering and forward sale agreement
The stock is listed on the NYSE
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares